AstraZeneca, in a move to increase its biologics manufacturing capacity in the United States, has acquired a high-tech biologics bulk manufacturing plant in Boulder, Colo., from Amgen Inc.
{iframe}http://www.bizjournals.com/philadelphia/blog/health-care/2015/09/astrazeneca-buys-boulder-amgen-facility.html?ana=e_phil_bn_newsalert&u=wjGEy67ABoSnsLErlc5ry0j5hx3&t=1441987751{/iframe}